Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01falseNo description of principal activity34truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09835294 2024-04-01 2025-03-31 09835294 2023-04-01 2024-03-31 09835294 2025-03-31 09835294 2024-03-31 09835294 c:Director1 2024-04-01 2025-03-31 09835294 c:RegisteredOffice 2024-04-01 2025-03-31 09835294 d:MotorVehicles 2024-04-01 2025-03-31 09835294 d:MotorVehicles 2025-03-31 09835294 d:MotorVehicles 2024-03-31 09835294 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09835294 d:ComputerEquipment 2024-04-01 2025-03-31 09835294 d:ComputerEquipment 2025-03-31 09835294 d:ComputerEquipment 2024-03-31 09835294 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09835294 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 09835294 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 09835294 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 09835294 d:CurrentFinancialInstruments 2025-03-31 09835294 d:CurrentFinancialInstruments 2024-03-31 09835294 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09835294 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09835294 d:ShareCapital 2025-03-31 09835294 d:ShareCapital 2024-03-31 09835294 d:RetainedEarningsAccumulatedLosses 2025-03-31 09835294 d:RetainedEarningsAccumulatedLosses 2024-03-31 09835294 c:FRS102 2024-04-01 2025-03-31 09835294 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09835294 c:FullAccounts 2024-04-01 2025-03-31 09835294 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09835294 6 2024-04-01 2025-03-31 09835294 d:DevelopmentCostsCapitalisedDevelopmentExpenditure d:OwnedIntangibleAssets 2024-04-01 2025-03-31 09835294 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure
Registered number: 09835294







UNAUDITED DIRECTOR'S REPORT AND FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 MARCH 2025


AIS HEALTH LIMITED







































 


AIS HEALTH LIMITED
 


 
COMPANY INFORMATION


Director
Dr A I Sheikh 




Registered number
09835294



Registered office
Tricorne Stables
15a Sandy Lane

Wokingham

Berkshire

RG41 4DD




Accountants
Menzies LLP
Chartered Accountants

3000a Parkway

Whiteley

Hampshire

PO15 7FX





 


AIS HEALTH LIMITED
 



CONTENTS



Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 7


 


AIS HEALTH LIMITED
REGISTERED NUMBER:09835294



STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
699
2,688

Tangible assets
 5 
24,121
32,162

Investments
 6 
50,000
-

  
74,820
34,850

Current assets
  

Debtors: amounts falling due within one year
 7 
2,907
320

Cash at bank and in hand
  
27,350
155,553

  
30,257
155,873

Creditors: amounts falling due within one year
 8 
(16,661)
(61,606)

Net current assets
  
 
 
13,596
 
 
94,267

Total assets less current liabilities
  
88,416
129,117

Provisions for liabilities
  

Deferred tax
  
(5,533)
(8,040)

  
 
 
(5,533)
 
 
(8,040)

Net assets
  
82,883
121,077

Page 1

 


AIS HEALTH LIMITED
REGISTERED NUMBER:09835294


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2025

2025
2024
£
£

Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
82,783
120,977

  
82,883
121,077


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 November 2025.




Dr A I Sheikh
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 


AIS HEALTH LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

AIS Health Limited is a private company, limited by shares, incorporated in England and Wales. The company's registered number and registered office address can be found on the Company Information page.                                                                                                                                                                                                                                             

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 


AIS HEALTH LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the reporting date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.


 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 4

 


AIS HEALTH LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Motor vehicles
-
25%
reducing balance
Computer equipment
-
25%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted Company shares, whose market value can be reliably determined, are remeasured to market value at each reporting date. Gains and losses on remeasurement are recognised in the Statement of Income and Retained Earnings for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

 
2.9

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.10

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 3 (2024 -4).

Page 5

 


AIS HEALTH LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

4.


Intangible assets




Development expenditure

£



Cost


At 1 April 2024
12,750



At 31 March 2025

12,750



Amortisation


At 1 April 2024
10,063


Charge for the year on owned assets
1,988



At 31 March 2025

12,051



Net book value



At 31 March 2025
699



At 31 March 2024
2,688




5.


Tangible fixed assets





Motor vehicles
Computer equipment
Total

£
£
£



Cost or valuation


At 1 April 2024
61,590
3,105
64,695



At 31 March 2025

61,590
3,105
64,695



Depreciation


At 1 April 2024
31,757
777
32,534


Charge for the year on owned assets
7,458
582
8,040



At 31 March 2025

39,215
1,359
40,574



Net book value



At 31 March 2025
22,375
1,746
24,121



At 31 March 2024
29,833
2,329
32,162

Page 6

 


AIS HEALTH LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


Fixed asset investments





Unlisted investments

£



Cost or valuation


Additions
50,000



At 31 March 2025
50,000





7.


Debtors

2025
2024
£
£


Trade debtors
-
187

Other debtors
2,907
133

2,907
320



8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
12,934
58,480

Other creditors
1,106
876

Accruals and deferred income
2,621
2,250

16,661
61,606



9.


Related party transactions

At the year end, included within creditors due within one year are amounts owed to the director by the company amounting to £1,106 (2024 - £875). This loan is undated and interest free.

 
Page 7